Chotiyarnwong, P.P.ChotiyarnwongMcCloskey, E. V.E. V.McCloskeyHarvey, N. C.N. C.HarveyLorentzon, M.M.LorentzonPrieto-Alhambra, D.D.Prieto-AlhambraAbrahamsen, B.B.AbrahamsenAdachi, J. D.J. D.AdachiBorgstrom, F.F.BorgstromBruyere, O.O.BruyereCarey, J. J.J. J.CareyClark, P.P.ClarkCooper, C.C.CooperCurtis, E. M.E. M.CurtisDennison, E.E.DennisonDiaz-Curiel, M.M.Diaz-CurielDimai, H. P.H. P.DimaiGrigorie, D.D.GrigorieHiligsmann, M.M.HiligsmannKhashayar, PatriciaPatriciaKhashayarLewiecki, E. M.E. M.LewieckiLips, P.P.LipsLorenc, R. S.R. S.LorencOrtolani, S.S.OrtolaniPapaioannou, A.A.PapaioannouSilverman, S.S.SilvermanSosa, M.M.SosaSzulc, P.P.SzulcWard, K. A.K. A.WardYoshimura, N.N.YoshimuraKanis, J. A.J. A.Kanis2022-08-262022-07-062022-08-2620221862-3522WOS:000817931200003https://imec-publications.be/handle/20.500.12860/40068Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working GroupJournal article10.1007/s11657-022-01117-6WOS:000817931200003BONE-MINERAL DENSITYRANDOMIZED CONTROLLED-TRIALVITAMIN-D SUPPLEMENTATIONESTROGEN PLUS PROGESTINHIP FRACTURECOST-EFFECTIVENESSOLDER WOMENGUIDELINE GROUPDOUBLE-BLINDTASK-FORCEMEDLINE:35763133